Www Discoverdatingservices G Webcam En Admissions Application Process Discover Dating Services China Pharmaceuticalm R&D Summit 2011

3:15

Innovative Drug Discovery Efforts in TOT RD Center
TOT RD Center focuses on developing cancer gene therapy/immune therapy technology and products, especially developing new oncolytic virus products. In this talk, the efforts and rationale of current oncolytic virus projects in TOT RD Center will be discussed.
Min Liang, Ph.D., General Manager, TOT Shanghai RD Center Co., Ltd.

主题演讲 (3个会议的共通会议)

4:00

Chairperson's Remarks and Introduction of Keynotes
Tony Zhang, Ph.D., Vice President, Global External R&D, Asia, Eli Lilly & Co.

4:05

Key Factors to Be Successful in Emerging Markets
Ruiping Dong, M.D., Ph.D., Senior Vice President, Head of Emerging Markets R&D, Merck Research Laboratories

4:35

Innovation in Protein Therapeutics Research and Development
Clive R. Wood, Ph.D., Senior Vice President, Head of Global Biologics, Bayer Healthcare

5:05

How to Introduce the Concept of "Change" in Biopharmaceuticals
Sam Waskal, Ph.D., Chairman & CEO, Kadmon Pharmaceuticals

5:35

Cocktail Reception in Exhibit & Poster Hall

总会: 中国的变革和技术革新

主题演讲

Panel Discussion

9:20

Dialogue Between the Stakeholders of Innovation in China Where Does Innovation Originate From? Locally or Globally?

Chinese government's innovation initiatives
Chinese government's investment in biotechnology firms in 12th 5 year planning phase
Role of MNCs in business growth/innovation in China
How can MNCs and domestic companies bridge the gap and leverage on each other's expertise, funding and resources?
How can MNCs assist in innovation initiatives by domestic companies?

Moderator: Kewen Jin, M.D., General Manager, Preclinical Services, Charles River Laboratories Greater China
Panelists:
Hongguang Wang, Ph.D., Director General, China National Center for Biotech Development, Ministry of Science & Technology China
Xian-Ping Lu, Ph.D., CEO & Chief Scientific Officer, Shenzhen Chipscreen Biosciences, Ltd.
Frank Jiang, M.D., Ph.D., Vice President & Head, China R&D, Sanofi-Aventis

Panel Discussion

10:50

Transformation & Innovation: Moving Up the Value Chain

What's the next stage for China's life sciences industry?
What are the pros and cons of the different approaches of global pharma?
How can China transform itself and expand from manufacturing and service to product and technology innovation?
Lessons learned from other industries
Global pharma R&D Productivity challenge and how China can help?

Moderator: Steve Yang, Ph.D., Vice President, Head of R&D, Asia, Pfizer Global Research & Development
Panelists:
Robert Armstrong, Ph.D., Vice President, Global External Research, Eli Lilly
Bin Li, Ph.D., Executive Director, Senior Equity Research Analyst, China Healthcare, Morgan Stanley
George Baeder, Senior Partner, Monitor Group
Li Chen, Ph.D., Chief Executive Officer, Hua Medicine

Showcase: IBC-BayHelix Class of 2010

创药到前临床开发、及合作

1:55

Chairperson's Opening Remarks
Stella Xu, Ph.D., Executive Director, Roche Partnering, Shanghai Roche (R&D) Center

透过合作的价值创造

2:00

Drug Discovery R&D in China: Opportunities and Challenges
To fully capitalize on the initial investment and turn China into a RED (research and early development) hub for global MNCs, several hurdles need to be overcome, especially in the early clinical development area. This lecture will highlight these challenges and opportunities.
Mingqiang Zhang, Ph.D., FRSC, Chief Technology Officer and Vice President of External Innovation, Roche Research and Early Development, China

2:30

Simcere's R&D: International Collaboration as a Major Strategy
Abstract not available at time of print.
Peng Wang, Ph.D., Chief Scientific Officer, Simcere Pharmaceuticals

3:00

Discover Dating Services Discover Dating Services Images Discover Dating Services

Www Discoverdatingservices G Webcam En Admissions Application Process Discover Dating Services China Pharmaceuticalm R&D Summit 2011 | 创药到前临床开发、及合作的议程